Patent ID: 11951335
Assignee: B.R.H. MEDICAL LTD.
Field: Medical technology (Instruments)
Classification: CPC A | IPC A

Claim 16:
17. The method of 16, wherein said pulmonary condition comprises at least one of: alveolar damage, vascular damage, lung ailment, respiratory disorder, respiratory disease, acute or subacute pulmonary pathology or ailment, lung or pulmonary lesions, severe acute respiratory syndrome, acute respiratory distress syndrome (ARDS), pulmonary ailment caused by coronavirus disease 2019 (COVID-19), respiratory failure, pulmonary insufficiency, progressive pulmonary disease, lung conditions encumbered with thrombosis, pulmonary embolism (PE), leakage of fibrin-rich fluid from pulmonary capillaries into alveoli, respiratory disease characterized by widespread inflammation of the lungs due to a buildup of fluid in the alveoli, ARDS caused by or a complication of sepsis, pneumonia, or COVID-19, pulmonary damage with alveolar granulation tissue.